Subscribe

Kyle Garland, PhD

Articles by Kyle Garland, PhD

Kyle Garland, PhD, on the Potential of mRNA-engineered iPSC-derived Cell Therapies for Solid Tumors

ByKyle Garland, PhD

May 19th 2023

The senior scientist at Eterna Therapeutics discussed the company’s numerous presentations at ASGCT’s 2023 conference.

Latest Updated Articles

© 2025 MJH Life Sciences^®

All rights reserved.